Dr. Lal PathLabs Limited (LALPATHLAB) Share Price
NSE · Healthcare · Diagnostics & Research · ISIN INE600L01024
Key metrics
- Market Cap
- ₹32,167 Cr
- P/E Ratio
- 59.22
- EPS
- 32.53
- Book Value
- 151.67
- P/B Ratio
- 12.73
- ROE
- 19.86%
- ROCE
- 37.4%
- Debt / Equity
- 0.08
- Net Margin
- 18.27%
- Revenue Growth
- 12.25%
- Profit Growth
- 3.62%
- Dividend Yield
- 1.04%
- 52W High
- ₹1,988.90
- 52W Low
- ₹1,272.60
- Market Cap Band
- large cap
- Face Value
- 10
Ratios computed from the annual results period ending 2026-03-31.
About Dr. Lal PathLabs Limited
Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers phlebotomist training programs. The company was founded in 1949 and is based in Gurugram, India.
- Headquarters
- Gurugram, India
- Employees
- 5,206
- Promoter Holding
- 54.71%
The full Dr. Lal PathLabs Limited analysis
Create a free account to open the complete LALPATHLAB deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.